
About Invitrx Therapeutics
Invitrx Therapeutics is a Healthcare company based in Irvine (United States) founded in 2003 by Habib Torfi. It develops cell therapy products for wound healing, aesthetics, and regenerative medicine. It operates on a B2B and D2C model. Its chief executive, as recorded, is Habib Torfi. Invitrx Therapeutics offers products and services including Reluma, Skin Grafts, and Cord Blood Stem Cell Products. Its focus areas include Life Sciences, Biotechnology, Stem Cell Products and Medical Applications. Its legal entity is Invitrx Therapeutics, Inc. Similar companies include Avidity Biosciences, Vividion Therapeutics and Korro Bio; 3 of its 3 listed similar companies have raised funding.
Company details
Invitrx Therapeutics, Inc. specializes in creating cell therapy products like skin grafts and stem cell solutions for applications in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Based in Irvine, California, the company manufactures these products in a state-of-the-art lab and focuses on research and development. They supply physicians and researchers with innovative solutions, emphasizing quality and safety in regenerative medicine.
- Headquarters Irvine, United States
- Founders Habib Torfi
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website invitrx.com
- Social LinkedIn X Facebook Instagram
- Legal Name Invitrx Therapeutics, Inc.
Products & Services of Invitrx Therapeutics
Invitrx Therapeutics offers a comprehensive portfolio of products and services, including Reluma, Skin Grafts, and Cord Blood Stem Cell Products.
Product for regenerative medicine in aesthetics and wound healing.
Solutions for burn patients and reconstructive procedures.
Products for stem cell research and clinical applications.
People of Invitrx Therapeutics
17 people are tracked at Invitrx Therapeutics (3 in leadership, 14 in board & advisors).
| Name | Role | Group |
|---|---|---|
Habib Torfi | Founder, CEO | Leadership |
Marco Zahedi | Chief Medical Officer | Leadership |
Ranjan Gupta | Chief Scientific Officer | Leadership |
Chen Wei-Cheng | Scientific Advisor | Board & advisors |
Wu Chung-Ken | Medical Advisor | Board & advisors |
Lawton W. Tang | Medical Advisor | Board & advisors |
Jonathan R. Pirnazar | Medical Advisor | Board & advisors |
Herbert Lamblet | Medical Advisor | Board & advisors |
Shyh-Mine Lii | Medical Advisor | Board & advisors |
Zain Kadri | Medical Advisor | Board & advisors |
Xerxez Calilung | Medical Advisor | Board & advisors |
Michael A. Meshkin | Medical Advisor | Board & advisors |
Gregory R.D. Evans | Medical Advisor | Board & advisors |
Jane A. Cases | Medical Advisor | Board & advisors |
Hassan Badday | Medical Advisor | Board & advisors |
Amel Touhmi | Medical Advisor | Board & advisors |
Lin Yu-Ming | Scientific Advisor | Board & advisors |
Complete people profiles for Invitrx Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Invitrx Therapeutics
Invitrx Therapeutics has 3 listed similar companies in our database, 3 of them funded. They include Avidity Biosciences, Vividion Therapeutics and Korro Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed similar companies of Invitrx Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Invitrx Therapeutics
Websites that share an audience with Invitrx Therapeutics (invitrx.com).
Websites whose visitors overlap most with Invitrx Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amberstonebio.com | 97% | View details | |||
| nkgenbiotech.com | 88% | 2.3K | #7,342,022 | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as Invitrx Therapeutics (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Invitrx Therapeutics
Invitrx Therapeutics was founded in 2003.
Invitrx Therapeutics is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Habib Torfi is the CEO of Invitrx Therapeutics, as recorded in our data. They have also founded this company.
Invitrx Therapeutics, Inc. specializes in creating cell therapy products like skin grafts and stem cell solutions for applications in aesthetics, wound closure, plastic surgery, and reconstructive procedures. Based in Irvine, California, the company manufactures these products in a state-of-the-art lab and focuses on research and development. They supply physicians and researchers with innovative solutions, emphasizing quality and safety in regenerative medicine.
Invitrx Therapeutics's top competitors include Avidity Biosciences, Vividion Therapeutics and Korro Bio.
Invitrx Therapeutics offers Reluma, Skin Grafts, and Cord Blood Stem Cell Products.
Invitrx Therapeutics operates through Invitrx Therapeutics, Inc..